Mircera Approval History
FDA Approved: Yes (First approved November 14, 2007)
Brand name: Mircera
Generic name: epoetin beta-methoxy polyethylene glycol
Dosage form: Injection
Treatment for: Anemia Associated with Chronic Renal Failure
Mircera (epoetin beta-methoxy polyethylene glycol) is an erythropoiesis-stimulating agent indicated for the treatment of anemia associated with chronic renal failure.
Development History and FDA Approval Process for Mircera
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.